» Articles » PMID: 15289312

Heat Shock Protein 90 Regulates the Metaphase-anaphase Transition in a Polo-like Kinase-dependent Manner

Overview
Journal Cancer Res
Specialty Oncology
Date 2004 Aug 4
PMID 15289312
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

We have shown previously that the molecular chaperone heat shock protein 90 (Hsp90) is required for a proper centrosome function. Indeed, this Hsp90 function seems to be reflected in Polo-like kinase stability. Inhibition of Hsp90 in HeLa cells results in cell cycle arrest either in G2 stage or at the metaphase-anaphase transition. Here, we show that this inhibition leads to inactivation of the anaphase-promoting complex or cyclosome by both dephosphorylation and induction of the spindle assembly checkpoint. Hsp90 inhibition compromises two of the main mitotic kinases, Polo-like kinase 1 (Plk1) and cdc2. Interestingly, this mitotic arrest does not occur in certain tumor cell lines where Hsp90 and Plk1 are not associated. Those cells are able to process mitosis successfully and have an active Plk1 despite Hsp90 inactivation. Therefore, it seems that Hsp90 regulates completion of mitosis depending on its association with Plk1.

Citing Articles

Hsp70 Promotes SUMO of HIF-1 and Promotes Lung Cancer Invasion and Metastasis.

Ling X, Wan J, Peng B, Chen J J Oncol. 2021; 2021:7873085.

PMID: 34868316 PMC: 8642011. DOI: 10.1155/2021/7873085.


Cytosolic and Mitochondrial Hsp90 in Cytokinesis, Mitochondrial DNA Replication, and Drug Action in Trypanosoma brucei.

Meyer K, Shapiro T Antimicrob Agents Chemother. 2021; 65(11):e0063221.

PMID: 34424040 PMC: 8522745. DOI: 10.1128/AAC.00632-21.


DNA-PKcs inhibition impairs HDAC6-mediated HSP90 chaperone function on Aurora A and enhances HDACs inhibitor-induced cell killing by increasing mitotic aberrant spindle assembly.

Yu L, Lang Y, Guo J, Cai J, Shang Z, Chen B Cell Cycle. 2021; 20(2):211-224.

PMID: 33404279 PMC: 7889180. DOI: 10.1080/15384101.2020.1867790.


The CINs of Polo-Like Kinase 1 in Cancer.

Cunningham C, MacAuley M, Vizeacoumar F, Abuhussein O, Freywald A, Vizeacoumar F Cancers (Basel). 2020; 12(10).

PMID: 33066048 PMC: 7599805. DOI: 10.3390/cancers12102953.


Complex karyotype AML displays G2/M signature and hypersensitivity to PLK1 inhibition.

Moison C, Lavallee V, Thiollier C, Lehnertz B, Boivin I, Mayotte N Blood Adv. 2019; 3(4):552-563.

PMID: 30782614 PMC: 6391664. DOI: 10.1182/bloodadvances.2018028480.